cephapirin has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bey, R; Godden, SM; Lago, A; Leslie, K; Ruegg, PL | 1 |
| Dinsmore, RP; Elia, R; Garry, FB; Lombard, JE; Prentice, D; Wenz, JR | 1 |
| Anderson, RJ; Cullor, JS; Gardner, IA; Guterbock, WM; Holmes, J; Perani, L; Van Eenennaam, AL | 1 |
| McCoy, GC; Morin, DE; Shanks, RD | 1 |
3 trial(s) available for cephapirin and Recrudescence
| Article | Year |
|---|---|
The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cattle; Cell Count; Cephapirin; Dairying; Female; Lactation; Mastitis, Bovine; Milk; Recurrence | 2011 |
Short communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle.
Topics: Animals; Cattle; Cephalosporins; Cephapirin; Clindamycin; Female; Injections, Intramuscular; Lactation; Logistic Models; Mammary Glands, Animal; Mastitis, Bovine; Recurrence | 2005 |
Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Cephapirin; Combined Modality Therapy; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Mastitis, Bovine; Microbial Sensitivity Tests; Oxytetracycline; Recurrence; Severity of Illness Index; Streptococcal Infections; Treatment Outcome | 1998 |
1 other study(ies) available for cephapirin and Recrudescence
| Article | Year |
|---|---|
Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Cephapirin; Cost-Benefit Analysis; Dairying; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Oxytocin; Penicillins; Recurrence | 1995 |